tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BriaCell adds UCLA Health as site in Phase 3 breast cancer study

BriaCell (BCTX) Therapeutics announces the addition of UCLA Health Jonsson Comprehensive Cancer Center to its ongoing pivotal Phase 3 clinical study evaluating Bria-IMT in combination with a checkpoint inhibitor versus physician’s choice in patients with advanced metastatic breast cancer, MBC. “The inclusion of UCLA Health underscores our strategy to partner with top-tier institutions to accelerate trial enrollment and execution,” said Dr. Giuseppe Del Priore, BriaCell’s Chief Medical Officer. “We remain confident in our timeline for sharing top-line data in 2026.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1